REDUCTION OF FACTOR VIIa ACTIVITY DURING HEPARIN THERAPY IS CAUSED BY INTERACTIONS WITH TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND ANTITHROMBIN (AT) (Englisch)
- Neue Suche nach: Hansen, J. B.
- Neue Suche nach: Svensson, B.
- Neue Suche nach: Sandset, P. M.
- Neue Suche nach: Thyssen, F.
- Neue Suche nach: Hansen, J. B.
- Neue Suche nach: Svensson, B.
- Neue Suche nach: Sandset, P. M.
- Neue Suche nach: Thyssen, F.
In:
HAEMOSTASIS
;
30
;
75
;
2000
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:REDUCTION OF FACTOR VIIa ACTIVITY DURING HEPARIN THERAPY IS CAUSED BY INTERACTIONS WITH TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND ANTITHROMBIN (AT)
-
Beteiligte:Hansen, J. B. ( Autor:in ) / Svensson, B. ( Autor:in ) / Sandset, P. M. ( Autor:in ) / Thyssen, F. ( Autor:in )
-
Erschienen in:HAEMOSTASIS ; 30 ; 75
-
Verlag:
- Neue Suche nach: Karger
-
Erscheinungsdatum:01.01.2000
-
Format / Umfang:75 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.15
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.15 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 30
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Genetic Heterogeneity in Hereditary ThrombophiliaReitsma, P. H. et al. | 2000
- 1
-
RISK OF SUBSEQUENT VENOUS THROM-BOEMBOLIC COMPLICATIONS IN CARRIERS OF THE PROTHROMBIN OR THE FACTOR V GENE MUTATION WITH A FIRST EPISODE OF DEEP-VEIN THROMBOSISSimioni, P. / Prandoni, P. / Lensing, A. W. A. / Manfrin, D. / Tormene, D. / Gavasso, S. / Girolami, B. / Sardella, C. / Prins, M. H. / Girolami, A. et al. | 2000
- 1
-
Aspirin in the Treatment and Prevention of Cardiovascular DiseaseGaziano, J. M. / Skerrett, P. J. / Buring, J. E. et al. | 2000
- 2
-
FACTOR XIII VAL34LEU POLYMORPHISM: FREQUENCY IN FAMILIAL THROMBPOHILIA PATIENTS AND THE LACK OF ITS EFFECT OF PLASMA FXIII LEVEL AND ACTIVITYBalogh, I. / Katona, E. / Karpati, L. / Pfliegler, G. / Muszbek, L. et al. | 2000
- 3
-
BIOCHEMICAL CHARACTERIZATION OF VAL34LEU MUTANT FACTOR XIIIMuszbek, L. / Wartiovaara, U. / Balogh, I. / Szoke, G. / Haramura, G. / Karpati, L. / Katona, E. / Harsfalvi, J. / Mikkola, H. / Palotie, A. et al. | 2000
- 4
-
THROMBOPHILIC STATE IN BEHCET'S DISEASEHoffman R, R. / Gavish, I. / Azam, A. / Bergman, R. / Lanir, N. / Brenner, B. et al. | 2000
- 5
-
4G/5G PAI-1 GENE PROMOTER POLYMORPHISM IS NOT ASSOCIATED WITH ACUTE CORONARY DISEASE IN PORTUGUESE PATIENTSAraujo, F. / Pereira, C. / Lacerda, P. / Monteiro, F. / Henriques, I. / Meireles, E. / Maciel, M. M. / Cunharibeiro, L. M. et al. | 2000
- 6
-
EFFECT OF THE ADMINISTRATION OF AN ANTI-TNF-A MONOCLONAL ANTIBODY IN A MODEL OF DIC INDUCED BY ENDOTOXIN IN RABBITSRodriguez, P. / Montes, R. / Montes, M. / Garcia, N. / Zabalegui, N. / Perez, A. / Rocha, E. et al. | 2000
- 7
-
IMMUNE RESPONSE AND DISSEMINATED INTRAVASCULAR COAGULATIONVitkovsky, Y. / Kuznik, B. et al. | 2000
- 8
-
A REVISED VIEW OF ANTITHROMBIN III`S MECHANISM OF ACTIONRomisch, J. / Dickneite, G. / Gray, E. / Souter, P. / Wiedermann, C. J. et al. | 2000
- 9
-
THE ANALYTICAL CHARACTERISTIC OF HEMOSTASIS FUNCTIONAL SYSTEM FOR THE PATIENTS WITH A MYOCARDIAL INFARCTION DURING THROMBOLYTIC THERAPYKiritchuk, V. F. / Malinova, L. I. / Brook, S. B. et al. | 2000
- 10
-
HYPOFIBRINOLYSIS IN OBESE CHILDREN. EFFECT OF WEIGHT LOSS AND INFLUENCE OF PAI-1 PROMOTER 4G/5G GENOTYPEEstelles, A. / Falco, C. / Dalmau, J. / Segui, R. / Berbel, O. / Espana, F. / Castello, R. / Aznar, J. et al. | 2000
- 11
-
Aspects of the Clinical Management of Hereditary Thrombophilia: A Personal PerspectiveMannucci, P. M. et al. | 2000
- 11
-
RANDOMISED STUDY COMPARING TREATMENT OF DEEP VENOUS THROMBOSIS OUTSIDE HOSPITAL WITH INPATIENT TREATMENT USING ONCE-DAILY SUBCUTANEOUS DALTEPARIN. I. HEALTH-RELATED QUALITY OF LIFEKentson, M. / Hallert, C. / Engquist, L. / Hansen, S. / Backman, K. / Carlsson, P. et al. | 2000
- 12
-
THE ROLE OF A RAPID SEMI-QUANTITATIVE D-DIMER TEST (DIMERTEST®) IN PATIENTS PRESENTING IN EMERGENCY DEPARTMENT (ED) FOR SUSPECTED DEEP VEIN THROMBOSIS (DVT) OF THE LOWER LIMBSSiragusa, S. / Quartero, L. / Tatoni, P. / Porta, C. / Mazzoleni, F. / Bressan, M. A. et al. | 2000
- 13
-
MARKERS OF HEMOSTATIC SYSTEM ACTIVATION DURING TREATMENT OF DEEP VEIN THROMBOSIS WITH SUBCUTANEOUS UNFRACTIONATED OR LOW MOLECULAR WEIGHT HEPARINPeternel, P. / Terbian, M. / Tratar, G. / Boic, M. / Salobir, B. / Stegnar, M. et al. | 2000
- 14
-
Stroke Prevention: Antiplatelet and Antithrombolytic TherapyDiener, H.-C. et al. | 2000
- 14
-
HOME TREATMENT OF DEEP-VEIN THROMBOSIS - AN OUT-PATIENT TREATMENT MODEL WITH ONCE DAILY INJECTION OF LMWH (INNOHEP) IN GRADUATED SYRINGESLapidus, L. / Borretzen, J. / Gronlund, T. H. / Fahlen, M. / Hasselblom, S. / Larson, L. / Nordstrom, H. / Stigendal, L. / Waller, L. et al. | 2000
- 15
-
MANAGING VENOUS THROMBOEMBOLISM IN THE EMERGENCY DEPARTMENT (ED): THE NEED TO OBJECTIVELY EVALUATE PATIENTS CLINICALLY SUSPECTED OF PROXIMAL GRATER SAPHENOUS VEIN (PGSV) THROMBOSISSiragusa, S. / Porta, C. / Quartero, L. / Mazzoleni, F. / Tatoni, P. / Falaschi, F. / Bressan, M. A. et al. | 2000
- 16
-
INTRACELLULAR MECHANISMS OF THE ACUTE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN HUMAN ENDOTHELIAL CELLS IN CULTURELupu, C. / Roquefeuil, S. / Kakkar, V. V. / Lupu, F. et al. | 2000
- 16
-
Antiphospholipid Syndrome: State of the Art with Emphasis on Laboratory EvaluationGreaves, M. et al. | 2000
- 17
-
INHIBITION BY EXTRACELLULAR CAMP OF PMA-INDUCED PGHS-2 EXPRESSION IN HUMAN PULMONARY MICROVASCULAR ENDOTHELIAL CELLSElalamy, I. / Said, F. A. / Singer, M. / Couetil, J. P. / Hatmi, M. et al. | 2000
- 18
-
RETINOIDS MODULATE THE HEMOSTATIC PROPERTIES OF MACRO- AND MICRO-VASCULAR ENDOTHELIAL CELLSMarchetti, M. / Vignoli, A. / Falanga, A. et al. | 2000
- 19
-
A MECHANISM FOR UROKINASE-INDUCED CHEMOTACTIC EFFECT DISTINCT FROM PROTEOLYTIC ACTIVITY AND BINDING TO UPARMukhina, S. / Stepanova, V. / Traktouev, D. / Poliakov, A. / Tkachuk, V. et al. | 2000
- 20
-
ANTICOAGULANT HEPARAN SULFATE PROTEOGLYCANS ARE EXPRESSED COORDINATELY WITH SERINE PROTEASE INHIBITORS IN THE OVARIAN FOLLICLE DURING THE REPRODUCTIVE CYCLEPrincivalle, M. / Hasan, S. / Hosseini, G. / Dong, J. / De Agostini, A. et al. | 2000
- 21
-
REDUCED EXPRESSION OF SOLUBLE ADHESION MOLECULES AFTER 1 YEAR TREATMENT WITH ATORVASTATIN AND SIMVASTATIN IN PATIENTS WITH ATHEROSCLEROSIS (3-T SUBSTUDY)Seljeflot, I. / Tonstad, S. / Hjermann, I. / Kleve, R. / Arnesen, H. et al. | 2000
- 22
-
ANTIOXIDANTS REDUCE LOCAL AND SYSTEMIC PAI-1 IN A PORCINE MODEL OF ANGIOPLASTYOrbe, J. / Rodriguez, J. A. / Grau, A. / Martinezcaro, D. / Paramo, J. A. et al. | 2000
- 23
-
THE EFFECT OF PULSATILE PNEUMATIC COMPRESSION OF ISCHEMIC LEGS ON COAGULATION AND NITRIC OXIDE METABOLITESGosk-Bierska, I. / Sutkowska, E. / Ygamian, A. / Alexewicz, P. / Wozniewski, M. / Drakwojakiewicz, M. / Wysokinski, W. E. et al. | 2000
- 24
-
POSTPRANDIAL HYPERTRIGLYCERIDEMIA (PHT) AND INHIBITION OF FIBRINOLYTIC ACTIVITY; RISK FACTORS FOR DEVELOPING CORONARY ARTERY DISEASE (CAD) IN THE ELDERLY?Borvik, T. / Hansen, J. B. / Nordoy, A. et al. | 2000
- 25
-
PLATELET AGGREGATION BY TRIGLYCERIDE AND APO E RICH LIPOPROTEIN REMNANTS EXTRACTED FROM PLASMA OF SUDDEN CARDIAC DEATH CASESSaniabadi, A. / Takeichi, S. / Umemura, K. et al. | 2000
- 26
-
INTESTINAL ABSORPTION PROPERTIES AND PHARMACODYNAMIC EFFECTS OF THE ORAL, DIRECT THROMBIN INHIBITOR H 376/95 AND ITS ACTIVE FORM MELAGATRANGustafsson, D. / Nystrom, J.-E. / Carlsson, S. / Bredberg, U. / Eriksson, U. / Gyzander, E. / Elg, M. / Antonsson, T. / Hoffman, K.-J. / Ungell, A.-L. et al. | 2000
- 26
-
Causes of Thrombophilia Yet to Be Discovered: A Personal ViewGriffin, J. H. / Deguchi, H. / Fernandez, J. A. et al. | 2000
- 27
-
Current Knowledge of the Platelet Glycoprotein IIb/IIIa Receptor Antagonists for the Treatment of Coronary Artery DiseaseBerkowitz, S. D. et al. | 2000
- 27
-
ANTITHROMBOTIC ANTIOXIDANT ENZYMIC AGENTS: DERIVATIVES OF SUPEROXIDE DISMUTASE AND CATALASE MODIFIED BY CHONDROITIN SULFATEMaksimenko, A. V. / Golubykh, V. L. / Tischenko, E. G. et al. | 2000
- 28
-
DEPLETION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND ANTI-THROMBIN (AT) DURING HEPARIN INFUSION CAUSES A TRANSIENT ACTIVATION OF COAGULATION AFTER DISCONTINUATION OF TREATMENTHansen, J. B. / Naalsund, T. / Sandset, P. M. / Svensson, B. et al. | 2000
- 29
-
EFFICACY OF SMALL SELECTIVE THROMBIN INHIBITORS ASSESSED BY IN VITRO ASSAYSStegnar, M. / Trampus-Bakija, A. / Hribar, H. / Fortuna, M. / Bratovic, L. / Marinko, P. / Zega, A.-M. / Kikelj, D. / Urleb, U. et al. | 2000
- 30
-
THROMBIN GENERATION THROUGH PLATELET AGGREGATION. PREVENTION EFFECT OF ASPIRINAltman, R. / Scazziota, A. / Rouvier, J. / Gonzalez, C. et al. | 2000
- 31
-
THE PRESENCE OF ANTI-BETA2-GLYCO-PROTEIN IGG ANTIBODIES IS ASSOCIATED WITH STROKE IN INFANTS: A CAUSAL ROLE FOR MATERNAL ANTIBODIES?Male, C. / Deveber, G. / Lanthier, S. / Foulon, D. / Vegh, P. / Andrew, M. / Mitchell, L. et al. | 2000
- 32
-
ANTIPHOSPHOLIPID SYNDROME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH RESPIRATORY FAILURE-HEPARIN PROPHYLAXISPetrova, D. / Boyanovski, B. / Baleva, M. / Marinov, H. / Genova, V. / Mladenova, A. / Ganev, V. et al. | 2000
- 33
-
EFFECTIVE STRATEGIES FOR TESTING FOR LUPUS ANTICOAGULANTSJoist, J. H. / Ross, C. / Jagadeesan, K. / Chance, D. / Eby, C. S. / Creer, M. H. et al. | 2000
- 34
-
SUBACUTE DIC STATUS DURING ACUTE VARICELLA INFECTION IN OTHERWISE HEALTHY CHILDREN: A PROSPECTIVE STUDYKavakli, K. / Kurugol, Z. / Vardar, F. / Ozkinay, F. / Ozkinay, C. / Cetinkaya, B. / Aydinok, Y. et al. | 2000
- 34
-
Does Inflammation Contribute to Thrombotic Events?Esmon, C. T. et al. | 2000
- 35
-
PREVALENCE OF GENETICALLY DETERMINED MAJOR THROMBOSIS RISK FACTORS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES (APL)Forastiero, R. / Martinuzzo, M. / Adamczuk, Y. / Varela, M. L. I. / Carreras, L. O. et al. | 2000
- 36
-
INCREASED RISK OF RECURRENT VENOUS THROMBOEMBOLISM (VTE) DURING HORMONE REPLACEMENT THERAPY (HRT) - RESULTS OF THE ESTROGEN IN VENOUS THROMBOEMBOLISM TRIAL (EVTET)Hoibraaten, E. / Qvigstad, E. / Arnesen, H. / Larsen, S. / Wickstrom, E. / Sandset, P. M. et al. | 2000
- 37
-
ASSESSMENT OF PATIENT CAPABILITY TO SELF-ADJUST THE ORAL ANTICOAGULANT DOSE: A MULTICENTER STUDY ON HOME USE OF A PORTABLE PROTHROMBIN TIME MONITOR (COAGUCHECK)Cosmi, B. / Palareti, G. / Moia, M. / Carpenedo, M. / Pengo, V. / Biasiolo, A. / Rampazzo, P. / Morstabilini, G. / Testa, S. et al. | 2000
- 38
-
METHRO II: DOSE-RESPONSE STUDY OF THE NOVEL ORAL, DIRECT THROMBIN INHIBITOR, H 376/95 AND ITS SUBCUTANEOUS FORMULATION MELAGATRAN, COMPARED WITH DALTEPARIN AS THROMBOEMBOLIC PROPHYLAXIS AFTER TOTAL HIP OR TOTAL KNEE REPLACEMENTEriksson, B. I. / Lindbratt, S. / Kalebo, P. / Bylock, A. / Frison, L. / Welin, L. / Dahl, O. / Gustafsson, D. et al. | 2000
- 39
-
A COMBINED APPROACH APPLIED BY EMERGENCY DEPARTMENT (ED) PHYSICIANS IN THE INITIAL MANAGEMENT OF ACUTE DEEP VEIN THROMBOSIS (DVT)Siragusa, S. / Porta, C. / Tatoni, P. / Quartero, L. / Falaschi, F. / Mazzoleni, F. / Bressan, M. A. et al. | 2000
- 40
-
THROMBOPHILIA, PREGNANCY AND THROMBOPROPHYLAXIS. THE OPTIMAL DOSE OF LMWHSBoda, Z. / Laszlo, P. / Pfliegler, G. / Tornai, I. / Rejto, L. / Schlammadinger, A. et al. | 2000
- 41
-
Cellular Consequences upon Factor VIIa Binding to Tissue FactorSiegbahn, A. et al. | 2000
- 41
-
EFFECTS OF MELAGATRAN, THE ACTIVE FORM OF THE ORAL, DIRECT THROMBIN INHIBITOR H 376/95, AND DALTEPARIN, ON THE ENDOGENOUS THROMBIN POTENTIAL IN VENOUS BLOOD FROM HEALTHY MALE SUBJECTSBostrom, S. L. / Sarich, T. C. et al. | 2000
- 42
-
ANTICOAGULATION CLINICS: A COST-BENEFIT ANALYSISTesta, S. / D Angelo, A. et al. | 2000
- 43
-
INTERACTION BETWEEN GPIIB/IIIA-INHIBITORS AND UNFRACTIONATED OR LOW MOLECULAR WEIGHT HEPARINHarder, S. / Klinkhardt, U. / Graff, J. / Westrup, D. / Esslinger, H. U. / Breddin, H. K. et al. | 2000
- 44
-
A New Approach to Antiplatelet Therapy: Inhibitor of GPIb/V/IX-vWF InteractionIkeda, Y. / Handa, M. / Murata, M. / Goto, S. et al. | 2000
- 44
-
PROPHYLACTIC DOSES OF ENOXAPARIN DO NOT SEEM TO HAVE AN IMPACT ON THE SYSTEMIC PERIOPERATIVE COAGULATION ACTIVITY IN NEPHRECTOMIZED PATIENTSSzczepanski, M. / Szostek, P. / Pypno, W. et al. | 2000
- 45
-
EFFECT OF H 376/95, AN ORAL, DIRECT THROMBIN INHIBITOR, VERSUS R-HIRUDIN AND ENOXAPARIN ON MARKERS OF THROMBIN GENERATION AND PLATELET ACTIVATION IN SHED BLOOD FROM HEALTHY MALE SUBJECTSSarich, T. C. / Wolzt, M. / Eriksson, U. G. / Mattsson, C. / Schmidt, A. / Elg, S. / Andersson, M. / Fager, G. / Gustafsson, D. et al. | 2000
- 46
-
POLYMORPHISMS IN THE PROTHROMBIN GENE AND THEIR ASSOCIATION WITH PLASMA PROTHROMBIN LEVELSCeelie, H. / Rosendaali, F. R. / Bertina, R. M. / Vos, H. L. et al. | 2000
- 47
-
GENE TRANSFER TO SPROUTING ENDOTHELIAL CELLS DURING VASCULOGENESISAlian, A. / Falk, H. / Panet, A. / Eldor, A. et al. | 2000
- 48
-
Physiological Function of Tissue Factor Pathway Inhibitor and Interaction with HeparinsSandset, P. M. / Bendz, B. / Hansen, J.-B. et al. | 2000
- 48
-
FRENCH MULTICENTER REGISTER FOR FACTOR V LEIDEN MUTATION: COMPARISON BETWEEN HOMOZYGOTES AND HETEROZYGOTESBiron, C. / Schved, J. F. / Aillaud, M. F. / Juhan, I. / Bauters, A. / Jude, B. / Pernod, G. / Polack, B. / Bridey, F. / De Prost, D. et al. | 2000
- 49
-
FREQUENCIES OF TWO PROTHROMBOTIC GENETIC MARKER IN THROMBOPHILIC PATIENTS AND BLOOD DONORS IN CROATIABingulac-Popovic / Grahovac, B. / Babic, I. / Drazic, V. / Lenz, B. / Godec, D. / Balija, M. / Grgicevic, D. et al. | 2000
- 50
-
APC RESISTANCE AND MUTATIONS IN THE APC CLEAVAGE SITES OF FACTOR VVan Der Neut Kolfschoten, M. / Dirven, R. J. / Tans, G. / Rosingi, J. / Vos, H. L. / Bertina, R. M. et al. | 2000
- 51
-
PROTHROMBOTIC ABNORMALITIES IN PATIENTS WITH INFLAMATORY BOWEL DISEASEAraujo, F. / Magro, F. / Dinis-Ribeiro, M. / Fraga, M. / Cunha-Ribeiro, L. M. et al. | 2000
- 52
-
PROTEIN C/S RATIO AN ACCURATE AND SIMPLE TOOL TO IDENTIFY CARRIERS OF PROTEIN C MUTATIONSLibourel, E. J. / Meinardi, J. R. / Ruiters, M. H. J. / Van Der Meer, J. et al. | 2000
- 53
-
THE INCIDENCE OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN 20210A MUTATION. INTERIM REPORTTormene, D. / Simioni, P. / Zerbinati, P. / Luni, S. / Prandoni, P. / Girolami, A. et al. | 2000
- 54
-
THE INCIDENCE OF THROMBOTIC MANIFESTATION IN THROMBOPHILIC CHILDREN: A PROSPECTIVE STUDYTormene, D. / Simioni, P. / Franz, F. / Gavasso, S. / Prandoni, P. / Girolami, A. et al. | 2000
- 55
-
THE ADDITION OF PURIFIED FACTOR IX NORMALIZED THE RESISTANCE TO HEPARIN-ANTITHROMBIN COMPLEX IN THROMBOPHILIACSMakris, P. E. / Foka, Z. / Pithara, E. et al. | 2000
- 56
-
PLASMINOGEN ACTIVATORS AND INHIBITORS IN BREAST CANCER. THEIR RELATIONSHIP WITH TUMOR INVASION AND METASTASISEstelles, A. / Castello, R. / Espana, F. / Vazquez, C. / Falco, C. / Segui, R. / Perez-Minguez, F. / Aznar, J. et al. | 2000
- 57
-
IMPAIRED LIVER REGENERATION AFTER PARTIAL HEPATECTOMY IN PLASMINOGEN DEFICIENT MICEMatsuo, O. / Tanaka, M. / Okada, T. / Ueshima, S. / Imano, M. / Calmeliet, P. / Collen, D. / Ohyanagi, H. et al. | 2000
- 57
-
Which Antiphospholipid Antibodies Should Be Measured in the Antiphospholipid Syndrome?Galli, M. et al. | 2000
- 58
-
HIGHLY EFFECTIVE, FIBRIN-SPECIFIC CLOT LYSIS WITHOUT INCREASE IN BLEEDING TIME BY A MUTANT OF PRO-UK (M5)Liu, J.-N. / Liu, J.-X. / Zuo, J.-L. / Zhang, J. / Pannell, R. / Gurewich, V. et al. | 2000
- 59
-
EFFECT OF MUTATING THE TRANS-GLUTAMINASE-REACTIVE SITE OF A2-ANTIPLASMIN ON ITS FIBRIN-CROSS-LINKINGLee, K. / Lee, C. / Tae, W.-C. / Jackson, K. / Christiansen, V. / Mckee, P. et al. | 2000
- 60
-
MONOCLONAL ANTIBODIES DETECT RECEPTOR-INDUCED BINDING SITES (RIBS) IN PLASMINOGEN INDUCED BY ITS INTERACTION WITH CELLSMiles, L. A. / Green, M. A. / Gong, Y. / Dodriguez-Lambies, N. / Jardi, M. / Felez, J. et al. | 2000
- 61
-
INHIBITION BY KALLIKREIN AND PREKALLIKREIN OF PLATELETS ACTIVATED BY THROMBIN OR ADPVeloso / Eckardt, A. / Niewiarowsk, S. et al. | 2000
- 62
-
INHIBITORY EFFECTS OF ANTIBODIES TO GP IIB/IIIA AND GP IB(ALPHA) ON PLATELET-DEPENDENT THROMBIN GENERATION IN THE PRESENCE OF HUVEC OR ECM AND FLOWThomas, S. / Metcalfe, P. / Rigsby, P. / Goodall, A. / Gray, E. et al. | 2000
- 63
-
EFFICIENT TYROSINE PHOSPHORYLATION OF PROTEINS AFTER ACTIVATION OF PLATELETS WITH THROMBIN DEPENDS ON INTACT GPIBDiaz-Ricart, M. / Estebanell, E. / Lozano, M. / Escolar, G. / Amieson, G. A. / Ordinas, A. et al. | 2000
- 64
-
DEFECTIVE PLATELET AGGREGATION AND INCREASED RESISTANCE TO THROMBOSIS IN PURINERGIC P2Y1 RECEPTOR-NULL MICELeon, C. / Hechler, B. / Vial, C. / Freund, M. / Dierich, A. / Lemeur, M. / Cazenave, J. P. / Gachet, C. et al. | 2000
- 65
-
ROLE OF NEGATIVELY CHARGED PHOSPHOLIPIDS OF PLATELET MEMBRANE ON THROMBUS FORMATION ON COLLAGENGalan, A. M. / Heijnen, H. / De Groot, P. G. et al. | 2000
- 66
-
ABSENCE OF VENOUS THROMBOEMBOLISM DURING ORTHOPEDIC SURGERY IN PATIENTS WITH FV LEIDEN MUTATION OR 20210 A ALLELE OF PROTHROMBIN GENECampos, M. / Morais, S. / Cabeda, J. M. / Justica, B. et al. | 2000
- 67
-
AN ECONOMIC EVALUATION OF TINZAPARIN IN TREATING PULMONARY EMBOLISMAnnemans, L. / Robays, H. / Rasmussen, J. A. / Lewis, D. N. / Kestens, D. / Gilles, B. et al. | 2000
- 68
-
AMBULATORY TREATMENT OF PROXIMAL DEEP VENOUS THROMBOSIS WITH LOW MOLECULAR WEIGHT HEPARIN (ENOXIPARIN)Guloglu, R. / Kurtoglu, M. / Necefli, A. et al. | 2000
- 69
-
ROLE OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN DIAGNOSIS AND STRATIFICATION IN MASSIVE OR LARGE PULMONARY EMBOLISMGutierrez-Fajardo, P. / Jerjes-Sanchez, C. / Ramirez-Rivera, A. et al. | 2000
- 70
-
ASSESSING THE GLOBAL COST OF DEEP VEIN THROMBOSIS (DVT) IN FRANCE AND IN ITALYLevy, E. / Gabriel, S. / Dinet, J. / Rudelli, G. et al. | 2000
- 71
-
HEMOSTATIC RISK FACTORS IN PATIENTS WITH COMBINED HYPERLIPEMIA (CHL) DURING FASTING AND POSTPRANDIALLY, BEFORE AND AFTER TREATMENT WITH SIMVASTATIN AND OMEGA-3 FATTY ACIDS (FA)Nordoy, A. / Bonaa, K. H. / Sandset, P. M. / Hansen, J. B. / Nilsen, H. et al. | 2000
- 72
-
CONGENITAL AND ACQUIRED RISK FACTORS OF THROMBOSIS IN WOMEN USERS OF ORAL CONTRACEPTIVES. CLINICAL ASPECTSMira, Y. / Aznar, J. / Estelles, A. / Vaya, A. / Ferrando, P. V. et al. | 2000
- 73
-
ULCERATIVE COLITIS IS NOT A RISK FACTOR FOR DEEP VEIN THROMBOSISWysokinski, W. E. / Waszczuk, E. / Paradowskil et al. | 2000
- 74
-
INFLAMMATORY REACTION, COAGULOPATHY AND ENDOTHELIAL DYSFUNCTION AS RISK FACTORS IN HEMODIALYSIS IN PATIENTS WITH CARDIOVASCULAR DISEASE (CVD)Matsuo, T. / Kario, K. et al. | 2000
- 75
-
REDUCTION OF FACTOR VIIa ACTIVITY DURING HEPARIN THERAPY IS CAUSED BY INTERACTIONS WITH TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND ANTITHROMBIN (AT)Hansen, J. B. / Svensson, B. / Sandset, P. M. / Thyssen, F. et al. | 2000
- 76
-
THROMBOGENICITY OF FACOTR IX CONCENTRATES IN A HEMOPHILIA B PATIENTPenner, J. / Hassouna, H. et al. | 2000
- 77
-
RECOMBINANT COAGULATION FACTOR VIIa MAY BE USED TO REVERSE THE EFFECT OF HEPARIN IN EXPERIMENTAL IN VIVO HEMOSTASISHolst, J. / Kristensen1, A. M. / Hedner, U. et al. | 2000
- 78
-
PLATELET- ACTIVATING FACTOR (PAF) IS AN IMPORTANT MEDIATOR FOR DESMOPRESSIN RESPONSE IN HEMOPHILIA A AND VON WILLEBRAND DISEASEKavakli, K. / Huseyinof, A. / Coker, I. / Aydinok, Y. / Nisli, G. et al. | 2000
- 79
-
CLINICAL EXPERIENCE WITH rFVIIa AS AN UNIVERSAL HAEMOSTATIC AGENTCampos, M. / Lima, M. / Morais, S. / Justica, B. et al. | 2000
- 80
-
EVALUATION OF THE IN VIVO EFFECT OF rFVIIa (NOVOSEVEN) USING THE CLOT SIGNATURE ANALYZER (CSA)Key, N. S. / Christie, B. A. / Jones, B. / Nelsestuen, G. L. et al. | 2000
- 81
-
FIBRINOLYSIS/PROTEOLYSIS BALANCE IN STABLE ANGINA PECTORIS IN RELATION TO ANGIOGRAPHIC FINDINGSParamo, J. A. / Fernandez J, O. J. / Alegria, E. / Martinez-Caro, D. et al. | 2000
- 82
-
INTRAVASCULAR TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND ACTIVATED FACTOR VII (FVIIa) IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION (MI) - A POPULATION-BASED CASE-CONTROL STUDYHansen, J. B. / Borvik, T. / Sandset, P. M. / Svensson, B. et al. | 2000
- 83
-
THE PROTECTIVE EFFECT OF FACTOR XIII VAL34LEU ON THE RISK OF MYOCARDIAL INFARCTION. H.C.LBarbosa, A. P. / Mansur, L. H. / Siqueira, D. S. P. / Costa, L. C. C. et al. | 2000
- 84
-
ELEVATED LEVELS OF D-DIMER IN PATIENTS WITH UNSTABLE ANGINA PREDICT HIGHER RISK OF THROMBOTIC COMPLICATIONSAguiar, C. / Ferreira, J. / Freire, I. / Seabra-Gomes, R. et al. | 2000
- 85
-
TISSUE FACTOR ACTIVITY AND THROMBIN GENERATION IN PATIENTS WITH UNSTABLE ANGINA TREATED WITH STANDARD OR LOW MOLECULAR WEIGHT HEPARINSGorski, J. / Birkholz-Golaszewska, A. / Wachnicka-Truty, K. / Kurek, P. / Korzeniowski, A. et al. | 2000
- 86
-
A NOVEL ULTRASOUND PROTOCOL FOR THE DIAGNOSIS OF SYMPTOMATIC RECURRENT DEEP-VEIN THROMBOSISPrandoni, P. / Lensing, A. W. A. / Bernardi, E. / Bagatella, P. / Villalta, S. / Frulla, M. / Piccioli, A. / Scarano, L. / Marchiori, A. / Tormene, D. et al. | 2000
- 87
-
VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS WITH LOW MOLECULAR WEIGHT HEPARIN (ENOXIPARINE) IN POLYTRAUMATIZED PATIENTS IN INTENSIVE CARE UNIT(ICU)Kurtoglu, M. / Guloglu, R. / Necefli, A. et al. | 2000
- 88
-
BROADENING THROMBOLYTIC THERAPY INDICATIONS IN PATIENTS WITH PULMONARY EMBOLISMJerjes-Sanchez, C. / Gutierrez-Fajardo, P. / Ramirez-Rivera, A. / Trevino, H. / Villarreal, I. / Bermudez, M. et al. | 2000
- 89
-
HIGH VERSUS LOW-DOSE UNFRACTIONATED HEPARIN IN THE TREATMENT OF ACUTE THROMBOPHLEBITIS OF THE THIGH. INTERIM REPORT OF A PROSPECTIVE RANDOMISED STUDYMarchiori, A. / Verlato, F. / Prandoni, P. / Camporese, G. / Sabbion, P. / Rosso, F. / Tanduo, C. / Andreozzi, G. M. / Girolami, A. et al. | 2000
- 90
-
TYPE II HEPARIN INDUCED THROMBOCYTOPENIA (HIT) TREATED WITH REFLUDAN-5 CASESMakris, P. E. / Velissaris, J. / Sidiropoulos, D. / Semoglou, C. H. / Dalainas, V. et al. | 2000
- 91
-
A SIMPLIFIED APPROACH FOR THE INITIAL MANAGEMENT OF CLINICALLY SUSPECTED ACUTE PULMONARY EMBOLISM (PE) AT EMERGENCY WARDS: AN INTERIM ANALYSISSiragusa, S. / Porta, C. / Falaschi, F. / Tatoni, P. / Mazzoleni, F. / Quartero, L. / Bressan, M. A. et al. | 2000
- 92
-
A RANDOMISED COMPARISON OF 2 DOSAGES OF ENOXAPARIN, TENOXICAM AND PLACEBO IN THE TREATMENT OF ACUTE SUPERFICIAL VEIN THROMBOSIS OF THE LOWER LIMBS; A PILOT STUDYDecousus, H. / Stenox Group et al. | 2000
- 93
-
THE EFFECT OF PERIPHERAL PNEUMATIC COMPRESSION ON WALKING ABILITIES AND PLATELET ACTIVITY IN THE PATIENTS WITH CLAUDICATIONSutkowska, E. / Gosk-Bierska, I. / Alexewicz, P. / Wozniewski, M. / Drak-Wojakiewicz, M. / Wysokinski, W. E. et al. | 2000
- 94
-
LOW-DOSE ORAL VITAMIN K - ALTERNATIVE MANAGEMENT OF ASYMTOMATIC OVER-ANTICOAGULATED PATIENTSGoncalves, L. / Neves, C. / Fraga, M. / Andion, I. / Aranda, D. / Cunha-Ribeiro, L. M. et al. | 2000
- 95
-
ANALYSIS OF THE PREDICTIVE POSITIVE VALUE FOR FV MUTATION, IN SAMPLES WITH A POSITIVE RESULT IN APC-R MODIFIED TESTFraga, M. / Araujo, F. / Aranda, D. / Faria, M. / Albuquerque, M. / Ventura, T. / Cunha-Ribeiro, L. M. et al. | 2000
- 96
-
T LYMPHOCYTES DEVELOP PROCOAGULANT ACTIVITY DUE TO EXPOSURE OF NEGATIVELY CHARGED PHOSPHOLIPIDSBarrowcliffe, T. W. / Jardi, M. / Rodriguez-Lambies, N. / Fabregas, P. / Felez, J. et al. | 2000
- 97
-
OB-GENE PROTEIN LEPTIN IS ABLE TO INDUCE MONOCYTIC TISSUE FACTOR EXPRESSIONQuehenberger, P. / Exner, M. / Schwarzinger, I. / Bierhaus, A. / Muellner, C. / Wagner, O. / Nawroth, P. P. / Speiser, W. et al. | 2000
- 98
-
TISSUE FACTOR (TF) DEPENDENT AND INDEPENDENT PROCOAGULANT ACTIVITY ASSOCIATED WITH DIFFERENTIATION OF HEMATOPOIETIC CELLSJardi, M. / Felez, J. / Rodriguez-Lambies, N. / Fabregas, P. / Barrowcliffe, T. W. et al. | 2000
- 99
-
RELATIONSHIP BETWEEN PLASMA HOMOCYSTEINE (HCY) LEVEL AND FACTORS ASSOCIATED WITH ENDOTHELIAL CELL INJURYScazziota, A. / Pons, S. / Gonzalez, C. / Altman, R. et al. | 2000
- 100
-
CIRCULATING LEVELS OF PRO-INFLAMMATORY CYTOKINES IN ISOLATED LIMB PERFUSIONFerroni, P. / Di Filippo, F. / Martini, F. / Spila, A. / Anza, M. / Garinei, R. / Principi, F. / Laurenzi, L. / Gazzaniga, P. P. / Guadagni, F. et al. | 2000
- 101
-
FAILURE OF INTRAVENOUS ASPIRIN TO SALVAGE MYOCARDIUM IN DOGS WITH A RESIDUAL CRITICAL STENOSIS AT REPERFUSIONLibersan, D. / Quan, E. / Merhi, Y. / Uzan, A. / Laperriere, L. / Latour, J.-G. et al. | 2000
- 102
-
THE IN VITRO INHIBITORY EFFECT OF MELAGATRAN ON CLOT BOUND THROMBINLebrazi, J. J. / Elalamy, I. / Samama, M. M. et al. | 2000
- 103
-
Paroxysmal Nocturnal Hemoglobinuria and the Risk of Venous Thrombosis: Review and Recommendations for Management of the Pregnant and Nonpregnant PatientRay, J. G. / Burows, R. F. / Ginsberg, J. S. / Burrows, E. A. et al. | 2000
- 103
-
THROMBELASTOGRAPHY - A SCREENING TOOL FOR IN VITRO MONITORING OF ANTICOAGULANT POTENTIAL IN TICK SALIVAMartin, P. G. / Trimnell, A. / Keeling, D. M. / Nuttall, P. / Kazimorova, M. / Paesen, G. et al. | 2000
- 104
-
WHY, WHEN AND HOW SHOULD TREATMENT WITH GP IIB/IIIA INHIBITORS BE MONITORED?Breddin, H. K. / Klinkhardt, U. / Graff, J. / Westrup, D. / Harder, S. et al. | 2000
- 105
-
RISK OF HAEMORRHAGE DURING ORAL ANTICOAGULANT THERAPYMorais, S. / Beatriz, H. / Garcia, D. / Goncalves, C. / Campos, M. / Justica, B. et al. | 2000
- 106
-
ACTIVATED PROTEIN C RESISTANCE IS COMMON IN CANCER PATIENTS AND IS ASSOCIATED WITH VENOUS THROMBOEMBOLISMLanir, N. / Haim, N. / Hoffman, R. / Haim, A. / Tsalik, M. / Brenner, B. et al. | 2000
- 107
-
TREND TO EFFICACY OF PROPHYLAXIS WITH ANTITHROMBIN CONCENTRATE IN PREVENTION OF THROMBOSIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH L-ASPARAGINASE: RESULTS OF THE PARKAA STUDYMitchell, L. / Hanna, K. / Andrew, M. et al. | 2000
- 108
-
RECURRENT VENOUS THROMBOEMBOLISM AND BLEEDING COMPLICATIONS DURING ANTICOAGULANT TREATMENT IN PATIENTS WITH CANCER AND VENOUS THROMBOSISPrandoni, P. / Lensing, A. W. A. / Piccioli, A. / Bernardi, E. / Bagatella, P. / Simioni, P. / Girolami, B. / Marchiori, A. / Schudeller, A. / Sabbion, P. et al. | 2000
- 109
-
COMPARISON OF VENOGRAPHY WITH ULTRASOUND FOR DETECTION OF VENOUS THROMBOSIS IN THE UPPER BODY IN CHILDREN: RESULTS OF THE PARKAA STUDYMitchell, L. / Chait, P. / Ginsberg, J. / Hanna, K. / Andrew, M. et al. | 2000
- 110
-
A PROSPECTIVE COHORT DETERMINING THE INCIDENCE OF THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH L-ASPARAGINASE: RESULTS OF THE PARKAA STUDYMitchell, L. / Abshire, T. / Hanna, K. / Andrew, M. et al. | 2000
- 111
-
THE PORTROMB PROJECT: HYPERHOMOCYSTEINEMIA AND MTHFR AS RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN YOUNG PEOPLEAraujo, F. / Mansilha, A. / Fraga, M. / Sampaio, S. / Ventura, T. / Henriques, I. / Monteiro, F. / Meireles, E. / Braga, A. / Cunha-Ribeiro, L. M. et al. | 2000
- 112
-
MULTIPLE ABNORMALITIES (GENETIC AND FUNCTIONAL) ARE MORE FREQUENTLY FOUND AMONG PROFOUND VENOUS THROMBOSIS PATIENTS THAN AMONG PATIENTS WITH STROKECabeda, J. M. / Estevinho, A. / Pereira, M. I. / Morais, S. / Justica, B. / Campos, M. et al. | 2000
- 113
-
ETHIOPATOGENIC RELATIONSHIP BETWEEN TROMBOPHILIC FACTORS AND THROMBOTIC EVENTSMilitaru, S. / State, M. / Brailescu, G. et al. | 2000
- 114
-
ADDED APC IN THE APC-RESISTANCE TEST ACTIVATES PLASMA PROTEIN CHassouna, H. / Quinn, C. / Roberts, J. et al. | 2000
- 115
-
THE C677T POLYMORPHISM OF THE METHYLENETETRAHYDROFOLATE REDUCTASE GENE (MTHFR) IS NOT A RISK FACTOR FOR VENOUS THROMBOSIS IN ARGENTINAVarela, M. L. I. / Adamczuk, Y. / Martinuzzo, M. / Forastiero, R. / Cerrato, G. / Puente, D. / Carreras, L. et al. | 2000
- 116
-
INCIDENCE OF HEPARIN INDUCED THROMBOCYTOPENIA TYPE II IN MEDICAL PATIENTS TREATED WITH SUBCUTANEOUS CALCIUM HEPARIN. INTERIM ANALYSISGirolami, B. / Stefani, P. M. / Tanduo, C. / Sabbion, P. / Fabris, F. / Prandoni, P. / Girolami, A. et al. | 2000
- 117
-
A PILOT STUDY FOR THROMBOPROPHYLAXIS WITH SUBCUTANEOUS RECOMBINANT HIRUDIN IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE IIHuhle, G. / Hoffmann, U. / Hoffmann, I. / Harenberg, J. / Heene, D. L. et al. | 2000
- 118
-
Factor V (His 1299 Arg) in Young Turkish Patients with Cerebral InfarctAkar, N. / Yilmaz, E. / Akar, E. / Deda, G. / Sipahi, T. et al. | 2000
- 118
-
ANTIBODIES DIRECTED TOWARDS REKOMBINANT HIRUDIN SHOW SIGNIFICANT EFFECTS ON R-HIRUDIN'S ACTIVITY AND PHARMACODYNAMICSHuhle, G. / Liebe, V. / Hoffmann, U. / Harenberg, J. / Heene, D. L. et al. | 2000
- 119
-
DANAPAROID THERAPY AND CROSS REACTIVITY: STUDY OF 117 HIT PATIENTSElalamy, I. / Lecrubier, C. / Potevin, F. / Horellou, M. H. / Gerotziafas, G. / Samama, M. M. et al. | 2000
- 120
-
NEUROLOGICAL COMPLICATIONS IN IMMUNE-MEDIATED HEPARIN-INDUCED THROMBOCYTOPENIAHarbrecht, U. / Pohl, C. / Greinacher, A. / Theuerkauf, I. / Biniek, R. / Hanfland, P. / Klockgether, T. et al. | 2000
- 121
-
ARE LOW MOLECULAR WEIGHT HEPARINS REALLY DIFFERENT? PHARMACOLOGIC AND CLINICAL OBSERVATIONSFareed, J. et al. | 2000
- 122
-
TREATMENT OF ACUTE DVT WITH THE LOW MOLECULAR WEIGHT HEPARIN (LMWH) REVIPARIN. RESULTS OF THE CORTES-STUDYNakov, J. R. / Kakkar, V. V. / Hach-Wunderle, V. / Breddin, H. K. et al. | 2000
- 123
-
Influence of Fibrinogen Degradation Products on Thrombin Time, Activated Partial Thromboplastin Time and Prothrombin Time of Canine PlasmaMischke, R. / Wolling, H. et al. | 2000
- 123
-
REVIPARIN IN THE TREATMENT OF ACUTE DVT. EFFECTS ON THE PHLEBOGRAPHIC OUTCOME. RESULTS OF THE CORTES-TRIALBreddin, H. K. / Kakkar, V. V. / Huch-Wunderle, V. / Nakov, R. et al. | 2000
- 124
-
EFFECT OF DIFFERENT TREATMENT REGIMENS ON MARKERS OF COAGULATION AND THROMBIN GENERATION IN PATIENTS WITH DEEP VEIN THROMBOSISKakkar, V. / Breddin, H. / Hach, V. / Nakov, R. et al. | 2000
- 125
-
INCIDENCE OF HEPARIN-INDUCED THROMBOCYTOPENIA AND HEPARIN-PF4-ANTIBODIES IN PATIENTS WITH DEEP VENOUS THROMBOSIS TREATED WITH UFH OR LMWHLindhoff-Last, E. / Nakov, R. / Mosch, G. / Breddin, H. K. / Bauersachs, R. et al. | 2000
- 126
-
META-ANALYSIS OF TREATMENT OF DEEP-VEIN THROMBOSIS WITH FIXED-DOSE, BODY-WEIGHT INDEPENDENT L O W - M O L E C U L A R - W E I G H T CERTOPARIN ON REDUCTION OF THROMBUS EXTENTIONHarenberg, J. / Kirchmeier, C. M. / Tolle, A. / Weidinger, G. / Breddin, K. H. et al. | 2000
- 131
-
Comparison of Different Methods to Measure Fibrinogen Concentration in Canine Plasma with Respect to Their Sensitivity towards the Fibrinogen Degradation Products X, Y and DMischke, R. / Menzel, D. / Wolling, H. et al. | 2000
- 139
-
Characterization of Murine Anti-Glycoprotein Ib Monoclonal Antibodies That Differentiate between Shear-Induced and Ristocetin/Botrocetin-Induced Glycoprotein Ib-von Willebrand Factor InteractionCauwenberghs, N. / Ajzenberg, N. / Vauterin, S. / Hoylaerts, M. F. / Declerck, P. J. / Baruch, D. / Deckmyn, H. et al. | 2000
- 148
-
Low-Molecular-Weight Heparins: Are They Interchangeable?van der Heijden, J. F. / Prins, M. H. / Buller, H. R. et al. | 2000
- 149
-
Endothelial Function, Variables of Fibrinolysis and Coagulation in Smokers and Healthy ControlsEnderle, M. D. / Pfohl, M. / Kellermann, N. / Haering, H. U. / Hoffmeister, H. M. et al. | 2000
- 158
-
Low-Molecular-Weight Heparins in the Management of Unstable AnginaAgnelli, G. / Sonaglia, F. et al. | 2000
- 159
-
Thrombolysis and Adjunctive Therapies in Acute Myocardial InfarctionHelft, G. / Worthley, S. G. / Zaman, A. G. / Samama, M. M. / Badimon, J. J. et al. | 2000
- 168
-
Improvement of Outcome in Patients with Acute Ischaemic Stroke Treated with FragminDan, G.-A. / Gonta, A. / Serbanescu, A. / Ionete, C. et al. | 2000
- 168
-
Deep Venous Thrombosis: Leukocyte Rheology at Baseline and after in vitro ActivationLoPresti, R. / Ferrara, F. / Canino, B. / Montana, M. / Caimi, G. et al. | 2000
- 170
-
Dalteparin, a Low-Molecular-Weight Heparin, Reduces Ischaemia/Reperfusion-Induced Liver Injury in Rats by Increasing the Hepatic Level of ProstacyclinOkajima, K. / Harada, N. / Uchiba, M. et al. | 2000
- 172
-
The Prothrombinase-Induced Clotting Test: A New Technique for the Monitoring of AnticoagulantsCalatzis, A. / Spannnagl, M. / Gempeler-Messina, P. / Kolde, H. J. / Schramm, W. / Haas, S. et al. | 2000
- 174
-
Morphological Differences between GPIb Antibody-Induced and Shear Stress-Induced Platelet AggregatesNomura, S. / Tandon, N. N. / Nakamura, T. / Kambayashi, J. et al. | 2000
- 189
-
von Willebrand Factor Antigen as a Prognostic Marker in Posttraumatic Acute Lung InjurySiemiatkowski, A. / Kloczko, J. / Galar, M. / Czaban, S. et al. | 2000
- 196
-
Antithrombotic Activity of Orally Administered Low Molecular Weight Heparin (Logiparin) in a Rat ModelHiebert, L. M. / Ping, T. / Wice, S. M. et al. | 2000
- 204
-
Formation, Inhibition and Clearance of Plasmin in vivoChandler, W. L. / Alessi, M. C. / Aillaud, M. F. / Vague, P. / Juhan-Vague, I. et al. | 2000
- 219
-
Anticoagulant Therapy Modifies Fibrinolytic Dysfunction in Chronic Atrial FibrillationRoldan, V. / Marin, F. / Marco, P. / Climent, V. / Martinez, J. G. / Monmeneu, J. V. / Bodi, V. / Sogorb, G. F. et al. | 2000
- 225
-
Intestinal Absorption of Low Molecular Weight Heparin in Animals and Human SubjectsNissan, A. / Ziv, E. / Kidron, M. / Bar-On, H. / Friedman, G. / Hyam, E. / Eldor, A. et al. | 2000
- 233
-
A Chronopharmacodynamic Study on Standard Heparin, a Low Molecular Weight Heparin (Nadroparin) and Danaproid: Establishing and Comparing the Daily Variations of These Drugs in RatsAbrial, D. / Blanc, A. / Rehailia, M. / Mismetti, P. / Bouchut, C. / Laporte-Simitsidis, S. / Decousus, H. / Buisson, B. et al. | 2000
- 243
-
Absence of Transplacental Passage of the Low Molecular Weight Heparin EnoxaparinDimitrakakis, C. / Papageorgiou, P. / Papageorgiou, I. / Antzaklis, A. / Sakarelou, N. / Michalas, S. et al. | 2000
- 249
-
Characteristics of Heparin-Induced Platelet Aggregates in Chronic Hemodialysis with Long-Term Heparin UseMatsuo, T. / Matsuo, M. / Kario, K. / Suzuki, S. et al. | 2000
- 258
-
Why Is the Standardization of Prothrombin Time a Problem?Talstad, I. et al. | 2000
- 268
-
Factor VIII Inhibitors in Two Families with Mild Haemophilia A: Structural Analysis of the MutationsKnobe, K. E. / Villoutreix, B. O. / Tengborn, L. I. / Petrini, P. / Ljung, R. C. R. et al. | 2000
- 281
-
Mathematical Derivative Applied to International Normalised Ratio and Analytical Variations in Oral Anticoagulant Therapy ControlIntrocaso, G. / Cuboni, A. / Ratto, A. / Foieni, F. et al. | 2000
- 290
-
Effect of Oral Anticoagulant Treatment on Markers for Calcium and Bone MetabolismKnapen, M. H. J. / Hellemons-Boode, B. S. P. / Langenberg-Ledeboer, M. / Knottnerus, J. A. / Hamulyak, K. / Price, P. A. / Vermeer, C. et al. | 2000
- 298
-
Determination of Phylloquinone and Menaquinones in Food. Effect of Food Matrix on Circulating Vitamin K ConcentrationsSchurgers, L. J. / Vermeer, C. et al. | 2000
- 308
-
Comparison of Different Assays for von Willebrand Factor in Hemodialysis PatientsBorawski, J. / Pawlak, K. / Mysliwiec, M. et al. | 2000
- 316
-
Severe Thrombotic Complications Associated with Activated Protein C Resistance Acquired by Orthotopic Liver TransplantationGillis, S. / Lebenthal, A. / Pogrebijsky, G. / Levy, Y. / Eldor, A. / Eid, A. et al. | 2000
- 321
-
Conjunctive Effects of the 5HT~2 Receptor Antagonist, Sarpogrelate, on Thrombolysis with Modified Tissue Plasminogen Activator in Different Laser-Induced Thrombosis ModelsYamashita, T. / Kitamori, K. / Hashimoto, M. / Watanabe, S. / Giddings, J. C. / Yamamoto, J. et al. | 2000
- 333
-
Economics of Hemophilia CareAledort, L. M. et al. | 2000
-
1st North Sea Conference on Thrombosis and Haemostasis Maastricht, The Netherlands, June 12-14, 2000| 2000